Download presentation
Presentation is loading. Please wait.
1
CLIA Hot Topics CLIA Gary Yamamoto
Centers for Medicare & Medicaid Services San Francisco Regional Office CLIA
2
STATISTICS CLIA Certification
Certificates Region IX Nation Waived 22,171 73% 181,270 71% PPMP 4,311 14% 36,255 Compliance 2,073 7% 19,553 8% Accreditation 1,712 6% 16,683 TOTAL 30,267 253,761 CLIA
3
STATISTICS Self-Determined Laboratory Types
Region IX Nation POL 50% 48% Pharmacy 4% Nursing Facility 6% Home Health Agency Hospital 3% Community Clinic Independent 2% CLIA
4
STATISTICS CLIA Certification - POL
Certificates Nation Waived 72,131 61% PPMP 29,017 24% Compliance 12,289 10% Accreditation 5,856 5% TOTAL 119,293 CLIA
5
STATISTICS CLIA Certification of Accreditation
Organization Nation COLA 44% CAP 39% TJC 15% AABB 1% ASHI 0.4% AOA 0.6% CLIA
6
IQCP CLIA Individualized Quality Control Plan (IQCP)
Replaces Equivalent Quality Control (EQC) CLIA
7
IQCP CLIA Pursuant to 42 CFR § 493.1256(d):
Unless CMS approves a procedure specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must. . .” CLIA
8
IQCP Facts Education and transition period started on January 1, 2014 On January 1, 2016, laboratories must be in compliance with their quality control choice or deficiencies will be cited CLIA
9
IQCP Policies Applies to CMS-certified, non-waived laboratories, covering all phases of the testing process May or may not reduce QC amount or frequency IQCP is optional; default is regulations CLIA
10
IQCP Education and Transition Period
CLIA certified laboratories should: Continue to follow existing quality control protocols Decide to implement IQCP or default quality control Plan and complete their transition accordingly, phasing out EQC, if applicable CLIA
11
IQCP Educational Outreach
Brochure 11: CLIA Individualized Quality Control Plan Introduction Brochure 12: Considerations When Deciding to Develop an IQCP Brochure 13: What is IQCP? CLIA
12
IQCP Educational Outreach
CMS, in collaboration with the CDC, released the IQCP Workbook Geared primarily towards physician office laboratories (POL) and other smaller laboratories CLIA
13
CLIA Interpretive Guidelines
Revised guidelines published on the CLIA website January 9, 2015 Summary of major changes included in S&C Memo CLIA January 2016 revision: Removal of EQC Addition of IQCP CLIA
14
CLIA Interpretive Guidelines Removal of CLSI Microbiology References
For the following requirements, references to CLSI documents have been removed: 42 C.F.R. § (e)(4) [Media QC] 42 C.F.R. § (b)(1 – 2) [Susceptibility] For additional information, refer to S&C Memo CLIA CLIA
15
CLIA Interpretive Guidelines Removal of CLSI Microbiology References
With the 01/09/2015 publication of the revised IG, microbiology laboratories will have 2 options for CLIA quality control: Follow all applicable CLIA quality control regulations Implement IQCP CLIA surveyors will cite laboratories for non-compliance CLIA
16
TEST Act – HR 6118 TEST Act – Taking Essential Steps for Testing Act of 2012 Amendment to the CLIA statute signed by the President on December 4, 2012 Clarifies that proficiency testing samples to be tested in the same manner as patient specimens, EXCEPT that no proficiency testing samples shall be sent to another laboratory for analysis CLIA
17
TEST Act – HR 6118 Allows the Secretary enforcement discretion for: Revocation of a laboratory’s CLIA certificate for proficiency testing referral Imposition of the 2-year owner/operator prohibition when the laboratory is sanctioned for proficiency testing referral CLIA
18
TEST Act – HR 6118 Regulations required to implement the TEST Act published May 2, 2014, and effective July 1, 2014 Final rule details hierarchical adverse actions for proficiency testing referrals by seriousness Defines when discretion will be applied and when revocation will be imposed CLIA
19
TEST Act – HR 6118 Adds definition to 42 CFR § for “repeat” proficiency testing referral A second instance in which a proficiency testing sample, or a portion of a sample, is referred, for any reason, to another laboratory for analysis prior to the laboratory’s proficiency testing program event cut-off date within the period of time encompassing the two prior survey cycles. Applies to all CLIA certificate types CLIA
20
Proficiency Testing Referral Category 1
Repeat PT referral or laboratory sends PT samples to another laboratory and reports that laboratory’s test results as it’s own CMS must impose: Revocation of the laboratory’s CLIA certificate Civil Money Penalty (CMP) CMS may impose: Owner prohibition Includes a provision for discretion in exempting the owner from the prohibition CLIA
21
Proficiency Testing Referral Category 2
Laboratory sends PT samples or the results of PT samples to another laboratory prior to, or on, the event cut-off date Referring laboratory reports its own PT sample results CMS must impose: Suspension/Limitation of the laboratory’s CLIA certificate Civil Money Penalty (CMP) Directed Plan of Correction CMS may impose: Any other alternative sanctions, as appropriate CLIA
22
Proficiency Testing Referral Category 3
Laboratory sends PT samples to another laboratory but no test results were receveid prior to the event cut-off date CMS must impose: Civil Money Penalty (CMP) Directed Plan of Correction CMS may impose: Any other alternative sanctions, as appropriate CLIA
23
Proficiency Testing Referral Narrow Exception
One-time, narrow exception carve-out for intentional PT referral Clarifies intentional PT referral carve-out with addition of the following terms/definitions: Reflex testing Confirmation testing Distributive testing CLIA
24
Proficiency Testing Referral Narrow Exception
CMS will consider the referral to be improper, but not intentional, and subject to alternative sanctions in accordance with 42 CFR § (c): If the referral is not a repeat proficiency testing referral It the referral is limited to reflex, confirmatory, or distributive testing If the sample was a patient specimen, the referral would have been in full conformance with written, legally accurate and adequate standard operating procedures for the laboratory’s testing of patient specimens CLIA
25
Proficiency Testing Referral Narrow Exception
Reflex Testing Confirmatory or additional laboratory testing that is automatically requested by a laboratory under its standard operating procedures for patient specimens when the laboratory’s findings indicate test result that are abnormal, are outside a predetermined range, or meet other pre-established criteria for additional testing CLIA
26
Proficiency Testing Referral Narrow Exception
Confirmatory Testing Testing performed by a second analytical procedure that could be used to substantiate or bring into question the results of an initial laboratory test CLIA
27
Proficiency Testing Referral Narrow Exception
Distributive Testing Laboratory testing performed on the same specimen, or an aliquot of it, that requires sharing it between two or more laboratories to obtain all data required to complete an interpretation or calculation necessary to provide a final reportable result for the originally ordered test When such testing occurs at multiple locations with different CLIA certificates, it is considered distributive testing CLIA
28
CLIA CLIA CLIA information can be found at the CMS Website:
IQCP Mailbox: CLIA Interpretive Guidelines Mailbox: CLIA
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.